BOSTON SCIENTIFIC CORP is 1.5x more valuable than Medline Inc. by market capitalization ($71.33 B vs $49.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MDLN | BSX |
|---|---|---|
| Market cap | $49.12 B | $71.33 B |
| US-listed rank | #322 | #239 |
| Revenue (latest FY) | $28.43B | $20.07B |
| Net income (latest FY) | $1.16T | - |
| Net margin | 4069.4% | - |
| P/E (trailing FY) | 0.0 | - |
| SEC filings | 103 | 1,009 |
BOSTON SCIENTIFIC CORP is 1.5x more valuable than Medline Inc. by market capitalization ($71.33 B vs $49.12 B).
In their latest fiscal years, Medline Inc. reported $28.43B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: Medline Inc. and BOSTON SCIENTIFIC CORP, or browse the full rankings.